-
Enhertu plus pertuzumab granted Priority Review in US as 1st-line treatment for patients with HER2-positive metastatic breast cancer
25 Sep 2025 03:31 GMT
… Drug Administration (FDA) grants Priority Review to applications for medicines … was stratified by prior treatment (de novo metastatic … 47;or DESTINY-Lung05 trials. Continued approval in … foundational medicines Faslodex (fulvestrant) and Zoladex (goserelin) and …
-
Advances of Drug-Loaded Microsphere Technology for Targeted Immunotherapy Against Prostate Cancer
19 Sep 2025 16:43 GMT
… , Phase 2 Trial (the TRENDY Trial). Int J … received goserelin microsphere + ARV-766 microsphere embolization treatment, and … as collaboration across clinical medicine, data science, and … Drug Delivery Applications: An Overview of Recent Advances. Pharmaceutics. …
-
Can Epithelial-Myoepithelial Carcinoma of the Breast Benefit from TROP2 Antibody-Drug Conjugate?
11 Sep 2025 19:58 GMT
… 2 gene test, and goserelin was given for ovarian … United States Food and Drug Administration (FDA) approved the application … her overall survival. Local treatment (radiofrequency ablation) may be … review of the literature. Medicine. 2020;99(42):e22665. …
-
<![CDATA[A Pediatric Emergency Nurse and Breast Cancer Survivor Shares Her Story]]>
23 Sep 2025 20:38 GMT
… nurse at Hackensack University Medical Center in Hackensack, New … pills daily and receives monthly injections of Zoladex (goserelin), a treatment … do you think your medical background has helped you … be intimidating having a medical person as a patient, …
-
<![CDATA[Being Diagnosed With Breast Cancer at 29: A Patient’s Perspective ]]>
22 Sep 2025 19:55 GMT
… room nurse at Hackensack University Medical Center in Hackensack, New … pills daily and receives monthly injections of Zoladex (goserelin), a treatment … I quickly called my doctor';s office. I stepped … me the route of treatment we were going to take …
-
<![CDATA[For Young Adults, A Cancer Diagnosis ‘Doesn’t Define Who You Are’]]>
20 Sep 2025 19:57 GMT
… emergency nurse at Hackensack University Medical Center.
Davis, who is the … anastrozole pills daily and receives monthly injections of Zoladex (goserelin), a treatment regimen … patient population, with the organization stating on its website that the …
-
Breast cancer drug ALERT: Seasoned medical writer Dr. Vernon Coleman CONDEMNS ZOLADEX saying itâs dangerous, ineffective and misused
18 Jul 2025 07:48 GMT
… research into pharmaceutical side effects, … trials involving 6,279 patients found that combining Zoladex (goserelin … treatment options and reject unnecessary, harmful medications.
Zoladex is a hormone therapy drug … natural remedies for preventative medicine and …
-
Camizestrant reduced the risk of disease progression or death by 56% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial
01 Jun 2025 12:10 GMT
… free survival (PFS). The trial evaluated switching to the camizestrant … how we think about drug resistance in this type … in Phase III trials for the treatment of HR-positive … outcomes with foundational medicines fulvestrant and goserelin and aims to …
-
Novartis announces phase III NATALEE trial of Kisqali reduces risk of recurrence in younger patients with early breast cancer
03 Jun 2025 12:31 GMT
… of recurrence and fewer treatment discontinuations due to adverse … anastrozole or letrozole) and goserelin if applicable. The primary … from China’s National Medical Products Administration. In MBC … across three phase III trials. The NCCN Guidelines also …
-
AstraZeneca & Daiichi Sankyo announce positive results from DESTINY-Breast09 phase III trial of Enhertu plus pertuzumab to treat HER2-positive metastatic breast cancer
03 Jun 2025 08:43 GMT
… DESTINY-Breast09 phase III trial showed Enhertu (trastuzumab … was stratified by prior treatment (de novo metastatic disease … 47;or DESTINY-Gastric06 trials. Continued approval in … with foundational medicines Faslodex (fulvestrant) and Zoladex (goserelin) and …
About
© 1995-2025